Events & Training for May 2014

CHI's Tenth Annual PEGS the essential protein engineering summit

05 May 2014 - 09 May 2014

Over 1,600 participants will gather in Boston’s vibrant seaport district for open forum discussions and collaboration at CHI’s flagship biologics event “PEGS the essential protein engineering summit”. The continued success of PEGS is driven by the growth in biologics worldwide, the quality of scientific programming presented and valuable networking opportunities.

Seaport World Trade Center, Boston, MA, USA

Tissue Models & Drug Screening Conference

06 May 2014 - 07 May 2014

Over the years, three-dimensional (3D) models have become more favored over two-dimensional models (2D) because they better mimic the in vivo environment. Though 3D models have the potential to reduce failure in early stage drug discovery, there are still many questions to be answered: What are the gaps that still exist between 3D and 2D models? How will we conduct research to fill those gaps and what technological developments are needed? Sessions for the meeting include: I. Engineering 3D Tissue Models II. 3D Models for Compound Characterization, Target Identification & Validation III. Complex Models of Cancer IV. 3D Models for Drug Safety Testing and Screening V. Advances in Phenotypic Screening and Functional Analysis VI. Stem Cells & iPS Cell-Based 3D Tissue Models

TBA, Berlin, Germany

Can the NHS afford to not fund innovative medicines?

06 May 2014

The meeting will set out the balances and checks on the approval of innovative medicines for use in the NHS, and debate whether the pendulum has now swung too far in favour of cost alone.

Royal Society Of Medicine, 1 Wimpole Street, LONDON, UK

Frontiers in prescribing: Drug interactions: 50 years of progress

07 May 2014

Learning aims of the meeting: To inform the audience on epidemiology, mechanisms and clinical consequences of drug-drug interactions in the modern therapeutic world.

Royal Society Of Medicine, 1 Wimpole Street, LONDON, UK

Drug Design & Medicinal Chemistry Conference

08 May 2014 - 09 May 2014

The meeting will provide a forum for scientists across multiple disciplines, from both industry and academia, to connect and share complementary perspectives. We will discuss emerging target classes, advances in antibody drug conjugates and other methods for targeted drug delivery, new approaches in flow chemistry, and much more. In addition to scientific presentations, we will have dedicated times for networking among delegates.

tbc Berlin, Germany

Peptide Therapeutics

08 May 2014 - 09 May 2014

This meeting will explore the burgeoning world of Peptide Therapeutics and how peptides are being engineered to penetrate tumors and conquer unmet medical needs. Improving peptide properties, such as stability and half-life, will also be discussed along with innovating routes of administration. Case studies will be presented that illustrate the progress made in developing efficacious peptide therapeutics, while leaders in the field point the way to the future for these promising drugs.

Seaport World Trade Center, Boston, MA, USA

Protein Kinases in Drug Discovery - Europe

08 May 2014 - 09 May 2014

This premier conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on drug discovery aspects within the protein kinases field. A balance of both academic and industry experts will facilitate discussion on the following areas: I. Validation of Novel Kinase Targets II. Current Progress in Drug Design III. Kinase Inhibitor Development IV. Lessons From Preclinical Model & Clinical Development (From the Bench to the Bedside) V. Selectivity and Off Pathway Toxicity

tbc Berlin, Germany

Big Data in Pharma

12 May 2014 - 13 May 2014

Big data technologies make it easier to work with and link large datasets, detect patterns in real time, predict outcomes, undertake dynamic risk scoring and test hypotheses. Applying big-data strategies to better inform decision making could generate huge value across the health-care system by optimizing innovation, improving the efficiency of research and clinical trials and building new tools for physicians, consumers, insurers and regulators.

Holiday Inn Regents Park, London, UK

Creativity, music and the brain: The power of music over the mind

13 May 2014

The conference will appeal to those who want to learn more about the power of music on the brain, especially the effects of music on individuals, as well as its role in society. The conference will be suitable for psychiatrists, neurologists, psychologists, musicians and doctors; and for those who wish to learn more about creativity, music and the brain.

Royal Society Of Medicine, 1 Wimpole Street, London, UK

Pain Therapeutics

19 May 2014 - 20 May 2014

Inadequate pain control remains a major problem across the world. There is an urgent and unmet need to manage pain-related problems accurately. With patent expiries set to impact the market there is a by demand for new therapeutic targets. This event will focus on the advances and challenges of pre-clinical and clinical aspects of pain drug development.

Holiday Inn Regents Park, London, UK

ADC Summit

19 May 2014 - 20 May 2014

Join us and hear case studies, presentations and round tables demonstrating how to maximise the therapeutic index of your ADC and how this form of empowered antibody is transforming next-generation antibody therapeutics. This must attend event will be delivered by true industry experts who will inform you of latest developments.

Holiday Inn Regents Park, London, UK

Mastering Medicinal Chemistry

21 May 2014 - 22 May 2014

Senior executives and industry thought leaders from Pfizer, Roche, Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, AbbVie, AstraZeneca and many more will participate in this year’s program with inspiring discussions on the future role of medicinal chemistry and its contribution to improved drug discovery rates. Senior level chemists from leading life science companies will also discuss how kinetics and residence time, targeted tissue delivery, and allosteric inhibitors enhance profiles or modulate difficult targets. Network and share case studies on difficult targets with industry leading chemists and senior thought leaders during panel discussions, guided roundtable discussions and dedicated exhibit hall hours.

Westin Boston Waterfront, Boston, MA, USA

PAIN: Novel Drug Targets and Screening Tools

21 May 2014 - 22 May 2014

Recent market research data shows that the overall world revenue for pain therapeutics will be approximately $68 billion in 2013. With an aging population and increase in prevalence of cancer, diabetes, arthritis and other disorders, the need for pain medications will continue to rise. Hence, it would be interesting to get some insights into what is really happening in the R&D pipeline for pain, as this will drive revenues going forward. Cambridge Healthtech Institute's seventh annual PAIN: Novel Drug Targets and Screening Tools conference brings together leading experts, from industry, academia and government/regulatory agencies, to discuss the latest developments and trends in pain research. This year the conference will continue its focus on innovative drug targets including ion channels and GPCRs, while bringing attention to epigenetic and genetic modulators of pain. The increasing role of biologics will be discussed, as well as, novel screening technologies and animal models that are helping validate some of these new targets and inhibitors.

Westin Boston Waterfront, Boston, MA, USA

Drug Discovery Summit

22 May 2014 - 23 May 2014

The Summit will consist of the following four co-located conferences: I. Bioanalytical Sensors This meeting will include discussion on advances in sensor development, the clinical application of bioanalytical sensors, single molecule sensing, and bio-electrochemical sensing. II. Metabolomics: Advances & Applications in Human Disease The conference will focus on the clinical aspects in the metabolomics field such as advances in metabolite markers for use in personalized medicine, novel computational approaches for metabolome assessment as well as developments in clinical assay standardization and qualification for the implementation of metabolite markers in clinical development of drug candidates. III. GPCR Structure, Function, and Drug Discovery The GPCR conference seeks to provide a forum for researchers from both industry and academia to exchange complimentary perspectives on the latest discovery. We will cover topics such as biased signaling, novel ligands, X-ray crystallography, and many more. Join us to discuss the future of drug discovery and the role of GPCRs! IV. Single Cell Analysis Come to learn about the latest advances in single cell genomics and imaging techniques, share ideas with colleagues and network with experts in the single cell analysis field.

Hyatt Regency Cambridge, MA, USA

Metabolomics - Advances & Applications in Human Disease

22 May 2014 - 23 May 2014

The conference will focus on the clinical aspects in the metabolomics field such as advances in metabolite markers for use in personalized medicine, novel computational approaches for metabolome assessment as well as developments in clinical assay standardization and qualification for the implementation of metabolite markers in clinical development of drug candidates.

Hyatt Regency Cambridge, MA, USA